Stephen D Silberstein (Fred Cohen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Machine Learning

Artificial Intelligence

Top Venues

Pain medicine (Malden, Mass.)

Current pain and headache reports

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen D Silberstein, Sarah M Bobker
Artificial intelligence and social media: (Appropriately) harnessing headache medicine's new arsenal in the 21st century. Headache 64 (6) (2024)
Stephen D Silberstein, Caroline V Brooks, Daniel Sun, Dawn C Buse, Michael L Reed, Kristina M Fanning, Richard B Lipton
Prevalence and burden of migraine in the United States: A systematic review. Headache (2024)
Stephen D Silberstein, Sarah M Bobker
Artificial intelligence and social media: (Appropriately) harnessing headache medicine's new arsenal in the 21st century. Headache 64 (6) (2024)
Stephen D Silberstein, Sarah M Bobker
Artificial intelligence and social media: (Appropriately) harnessing headache medicine's new arsenal in the 21st century. Headache 64 (6) (2024)
Stephen D Silberstein, Caroline V Brooks, Daniel Sun, Dawn C Buse, Michael L Reed, Kristina M Fanning, Richard B Lipton
Prevalence and burden of migraine in the United States: A systematic review. Headache 64 (5) (2024)
Stephen D Silberstein, Caroline V Brooks, Daniel Sun, Dawn C Buse, Michael L Reed, Kristina M Fanning, Richard B Lipton
Prevalence and burden of migraine in the United States: A systematic review. Headache 64 (5) (2024)
Stephen D Silberstein, Caroline V Brooks, Daniel Sun, Dawn C Buse, Michael L Reed, Kristina M Fanning, Richard B Lipton
Prevalence and burden of migraine in the United States: A systematic review. Headache 64 (5) (2024)
Stephen D Silberstein, Sarah M Bobker
Artificial intelligence and social media: (Appropriately) harnessing headache medicine's new arsenal in the 21st century. Headache (2024)
Edmond Ahdoot, Stephen D Silberstein
Unraveling the MSG-Headache Controversy: an Updated Literature Review. Current pain and headache reports (2023)
Stephen D Silberstein, Jenn Vallimont, Amy A Gelfand
Caution regarding fabricated citations from artificial intelligence. Headache (2023)
Stephen D Silberstein
The role of artificial intelligence in headache medicine: Potential and peril. Headache (2023)
Stephen D Silberstein
The role of artificial intelligence in headache medicine: Potential and peril. Headache 63 (5) (2023)
Stephen D Silberstein
The role of artificial intelligence in headache medicine: Potential and peril. Headache 63 (5) (2023)
Stephen D Silberstein, Sarah M Bobker
From diet to disasters, lifestyle factors can affect headaches and migraine. Headache (2023)
Stephen D Silberstein
The role of artificial intelligence in headache medicine: Potential and peril. Headache 63 (5) (2023)
Fred Cohen, Hsiangkuo Yuan, E M G DePoy, Stephen D Silberstein
The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (3) (2022)
Stephen D Silberstein, Cynthia Armand, Richard B Lipton, Sarah Vollbracht
Efficacy and Tolerability of Calcitonin Gene-Related Peptide-Targeted Monoclonal Antibody Medications as Add-on Therapy to OnabotulinumtoxinA in Patients with Chronic Migraine. Pain medicine (Malden, Mass.) 22 (8) (2021)
Stephen D Silberstein, Benjamin W Friedman
A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis. Headache 61 (8) (2021)